Join our upcoming webinar to explore the recent advancement in GARD® for Skin Sensitization assessment, with a specific focus on substances that fall outside the applicability domains of the conventional in vitro assays in the OECD Test Guidelines. Our skin sensitization experts will address challenges posed by various Difficult-to-Test substances, discussing the applicability domain of […]
Spotlight on Applicability Domain, Quantitative Potency Assessment and Medical Devices In case you missed SenzaGen’s poster presentations and scientific session at this year’s SOT, we are pleased to offer you a new opportunity to participate on April 23, 2024! In this webinar Dr Andy Forreryd, SenzaGen's in vitro toxicology expert, will summarize the latest GARD data from industry collaborations: […]
Join us for a special re-run of our popular GARD® webinar to explore the recent advancement in Skin Sensitization testing, focusing on substances that fall outside the applicability domains of the conventional in vitro assays in the OECD Test Guidelines. Our skin sensitization experts will address challenges posed by various "Difficult-to-Test" substances, discussing the applicability […]
Join SenzaGen and industry leaders from Clarins and Bic Skin Creative for an in-depth webinar on using GARD® assays for skin sensitization testing. Learn how this innovative technology overcomes the unique challenges of testing complex Natural Extracts, which often fall outside the scope of traditional methods in OECD 442E Test Guidelines. Through case studies, we will showcase […]
Advancing NAMs for Skin Sensitization Testing: Natural Extracts, Medical Devices and Potency Join our upcoming webinar, where SenzaGen’s expert and guest speakers from dōTERRA and Risk Science Consortium will share insights and case studies on the use of New Approach Methodologies (NAMs) for skin sensitization assessment. We’ll present the latest GARD® data from our research […]
